These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1832806)

  • 1. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.
    Chengalvala M; Lubeck MD; Davis AR; Mizutani S; Molnar-Kimber K; Morin J; Hung PP
    Vaccine; 1991 Jul; 9(7):485-90. PubMed ID: 1832806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.
    Chengalvala MV; Bhat BM; Bhat R; Lubeck MD; Mizutani S; Davis AR; Hung PP
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():125-31. PubMed ID: 8113721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.
    Morin JE; Lubeck MD; Barton JE; Conley AJ; Davis AR; Hung PP
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4626-30. PubMed ID: 2955413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.
    Lubeck MD; Davis AR; Chengalvala M; Natuk RJ; Morin JE; Molnar-Kimber K; Mason BB; Bhat BM; Mizutani S; Hung PP
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6763-7. PubMed ID: 2570422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees.
    Chengalvala MV; Bhat BM; Bhat RA; Dheer SK; Lubeck MD; Purcell RH; Murthy KK
    Vaccine; 1997 Feb; 15(3):335-9. PubMed ID: 9139496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron.
    Mason BB; Davis AR; Bhat BM; Chengalvala M; Lubeck MD; Zandle G; Kostek B; Cholodofsky S; Dheer S; Molnar-Kimber K
    Virology; 1990 Aug; 177(2):452-61. PubMed ID: 2371766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.
    Tacket CO; Losonsky G; Lubeck MD; Davis AR; Mizutani S; Horwith G; Hung P; Edelman R; Levine MM
    Vaccine; 1992; 10(10):673-6. PubMed ID: 1523878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response to hepatitis B vaccine in premature neonates.
    Chawareewong S; Jirapongsa A; Lokaphadhana K
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):39-40. PubMed ID: 1835140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens.
    Soulié JC; Devillier P; Santarelli J; Goudeau A; Vermeulen P; Guellier M; Saliou P; Hillion AM; Tron F; Huchet J
    Vaccine; 1991 Aug; 9(8):545-8. PubMed ID: 1837646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.
    Ye WW; Mason BB; Chengalvala M; Cheng SM; Zandle G; Lubeck MD; Lee SG; Mizutani S; Davis AR; Hung PP
    Arch Virol; 1991; 118(1-2):11-27. PubMed ID: 1828660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children.
    Wiström J; Gustafsson A
    Scand J Infect Dis; 1990; 22(5):621-2. PubMed ID: 2148015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees.
    Natuk RJ; Lubeck MD; Chanda PK; Chengalvala M; Wade MS; Murthy SC; Wilhelm J; Vernon SK; Dheer SK; Mizutani S
    AIDS Res Hum Retroviruses; 1993 May; 9(5):395-404. PubMed ID: 8318268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.
    Leroux-Roels G; Van Hecke E; Michielsen W; Voet P; Hauser P; Pêtre J
    Vaccine; 1994 Jul; 12(9):812-8. PubMed ID: 7975860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative analysis of the humoral immune response to the "a" determinant of HBs antigen after inoculation with plasma-derived or recombinant vaccine.
    Waters JA; O'Rourke SM; Richardson SC; Papaevangelou G; Thomas HC
    J Med Virol; 1987 Feb; 21(2):155-60. PubMed ID: 2434612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
    Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
    N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of recombinant hepatitis B vaccine.
    Ohmura T; Ohmizu A; Sumi A; Ohtani W; Uemura Y; Arimura H; Nishida M; Kohama Y; Okabe M; Mimura T
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1172-8. PubMed ID: 2962578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular response and anti-HBs synthesis in vitro after vaccination with yeast-derived recombinant hepatitis vaccine.
    Degrassi A; Mariani E; Honorati MC; Roda P; Miniero R; Capelli M; Facchini A
    Vaccine; 1992; 10(9):617-22. PubMed ID: 1386954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers.
    Reutter J; Bart PA; Francioli P; Safary A; Frei PC
    J Viral Hepat; 1998 May; 5(3):205-11. PubMed ID: 9658375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.